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ABSTRACT 
 
While various sampling methods exist for collecting and enumerating airborne 
bacteria and fungi, no credible methodology has yet been developed for airborne 
viruses. A new sampling method for monitoring the personal exposure to bioaerosol 
particles has recently been developed and evaluated with bacteria and fungi. In this 
method, bacterial/fungal aerosol is aspirated and transported through a porous 
medium, which is submerged into a liquid layer. As the air is split into numerous 
bubbles, the particles are scavenged by these bubbles and effectively removed. The 
current feasibility study was initiated to evaluate the efficiency of the new personal 
sampler prototype (“bubbler”) with airborne viable viruses.  Two common viral 
strains, Influenza (stress-sensitive) and Vaccinia (robust), were aerosolized in the test 
chamber and collected by two identical “bubblers” that operated simultaneously for 
the duration of up to 5 minutes. A virus maintenance liquid, proven to be the 
optimum collecting environment for the test organisms, was used as a collection 
fluid.  After sampling, the collecting fluid was analyzed and the viral recovery rate 
was determined.  The overall recovery (affected not only by the sampling but also by 
the aerosolization and the aerosol transport) was 20% for Influenza virus and 89% for 
Vaccinia virus.  The new sampling method was found feasible for the collection and 
enumeration of robust airborne viruses.    
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INTRODUCTION 
 
 The SARS outbreak has raised various scientific and public health issues 
related to the transmission and control of infectious agents (Lipsitch et al., 2003). The 
threat of bioterrorism has gained additional public attentions to these issues. The 
above factors, as well as a generally growing concern about human exposure to 
bioaerosols, have created a considerable demand for advanced, reliable and efficient 
monitoring methods for detecting, identifying and enumerating airborne biological 
particles (Lacey and Dutkiewicz, 1994; Comtois and Isard, 1999). The requirements 
for an ideal bioaerosol sampler have been described by Macher (1997). One of the 
main questions in the selection of a bioaerosol sampler is whether it can maintain 
high biological collection efficiency, i.e., whether the effect of the sampling on the 
biological status of the collected microorganisms can be minimized.    
  Individual exposure to bioaerosols can be adequately evaluated by the use of 
personal aerosol samplers.  The following criteria are applied to the bioaerosol 
sampling: (i) the sampler should be compact and capable of maintaining high physical 
and biological efficiencies over prolonged time periods, and (ii) the collection media 
should be suitable for a variety of microbiological analyses, including microbial 
identification and enumeration (Crook, 1995). 
 Based on the engineering control method, which was previously applied to the 
removal of particles from gas carriers (Agranovski et al., 1999; Agranovski et al., 
2001), a new personal bioaerosol sampling method was developed (Agranovski et al., 
2002a; Agranovski et al., 2002b). The prototype device is shown in Figure 1.  Front 
(a) and side (b) views photographs are presented along with the diagrams of the top 
(c) and vertical cut (d) of the sampler.  Contaminated air, aspirated into the air inlets, 
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is bubbled through a porous medium, which is submerged into a liquid layer, and 
subsequently split into a multitude of very small bubbles. The particulates are 
scavenged by these bubbles, and, thus, effectively removed before the effluent air 
leaves the vessel. The performance characteristics of the new sampler have been 
evaluated in a stationary operation mode with PSL particles and found to exceed 92% 
for the particles of 0.318 µm and larger (Agranovski et al., 2002a). An 8-hour 
continuous sampling of airborne bacteria of Pseudomonas fluorescens and Bacillus 
subtilis var. niger and airborne fungal spores of Aspergillus versicolor revealed that 
the viability of these microorganisms remained high (Agranovski et al., 2002b). The 
recovery rate of the stress-sensitive gram-negative P. fluorescens bacteria was 
61±20%. For stress-resistant B. subtilis bacteria and A. versicolor fungal spores it was 
95±9% and 97±6%, respectively. The field study, in which six identical personal 
samplers were tested simultaneously on a simplified human manikin in an office 
environment during 2-, 4- and 8-hour time intervals, has shown that the viable 
microbial concentration was not significantly affected by the sampling time. This was 
attributed to a gentle collection process utilized in this novel bioaerosol sampling 
method. The inter-sample variation did not exceed 30%. Thus, the new sampling 
method was found suitable for both the stationary and personal monitoring of airborne 
bacteria and fungal spores.   
 Viruses generally exhibit much stronger response to microbial stress than 
bacteria and fungi. For this reason, there is a lack of methods for efficient collection 
of airborne viruses, although a variety of reasonably well characterized sample 
collection techniques are available for aerosolized bacteria and fungi. In most 
existing bioaerosol samplers, such as impactors and impingers, the microorganisms 
impact on the collection media at air velocity as high as tens and hundreds m s-1 
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(Mainelis et al., 1999). This creates excessive microbial stress during the sampling. In 
contrast, the new sampler was designed to operate at an air velocity below 1 m s-1 to 
minimize the stress.   
 Our first (pilot) study addressed the survival of viruses in a bubbling 
collection fluid (Agranovski et al., 2003). The decay of viable viruses in the 
suspension, subjected to continuous bubbling inside the sampler’s collection vessel, 
was determined for three stress-sensitive (Influenza, Mumps and Measles) and one 
robust (Vaccinia) viral strains. The HEPA-filtered air was continuously drawn 
through the virus-containing fluid at a flowrate of 4 L min-1 during the time of up to 4 
hours. The experiments were performed with two types of fluids, including sterile 
water and a specially prepared virus maintenance fluid with an antifoaming agent. 
Fluid samples were taken at 0, 1, 2 and 4 hours and analyzed by appropriate 
microbiological techniques to quantify the viral response to the stress caused by the 
bubbling. The natural decay was also measured (for a stationary suspension with no 
bubbling) and used for comparison. Overall, the survival rate was relatively high 
given such a prolonged exposure of viruses to the stress. For stress-sensitive strains, 
the decay was especially pronounced when testing with sterile water: it exceeded 
99% after 4 hours of the device operation. In contrast, the robust Vaccinia virus did 
not show any noticeable decay for the entire 4-hour period. The use of the virus 
maintenance fluid significantly decreased the decay (75%) for stress-sensitive 
microorganisms. The difference in the physical properties of this fluid and the sterile 
water did not seem to affect the physical performance characteristics of the 
“bubbler.” No excessive foam generation was observed during its operation; the 
physical sampling efficiency of the device was the same with both fluids; and no 
increase in the hydrodynamic resistance was detected. Therefore, the pilot study data 
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suggested that the virus maintenance fluid is suitable for maintaining viability of 
airborne viruses (especially robust ones) should they be collected by the new 
sampling method during several hours.  
 In this study, the new sampler was evaluated with the viable viruses 
aerosolized in the test chamber and actually collected from the air into the device 
containing the virus maintenance fluid. The bioaerosol samples obtained during a 5-
minute continuous operation of the “bubbler” were analysed to determine the 
recovery rate of the collected viruses. 
 
 METHODS 
 
Test Viruses  
 Two common viruses with an aerosol transmission pathway, Influenza and 
Vaccinia were employed for the tests (see the photo in Figure 2). Both were 
previously tested with respect to their survival through continuous bubbling processes 
and found to have distinctly different stress-resistance characteristics: Vaccinia was 
much more stress-resistant than Influenza (Agranovski et al., 2003).  
 Influenza virus A/Aichi/2/68 (H3N2) was obtained from the Moscow 
Ivanovsky Institute of Virology. The virus was passaged 12 times in mice and twice 
in embryonated chicken eggs (ECE). Allantoic fluid, which was produced by 
cultivating the virus in ECE (9–11 day old) and had a viral concentration of 108 – 109 
EID50 mL-1, was used in the experiments. The EID50 is commonly defined as the 
smallest amount of virus capable of initiating infection in an embryonated egg on 
50% of occasions (Barrett and Inglis, 1985). 
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 Vaccinia virus strain LIVP (C0355 K0602) was also obtained from the 
Moscow Ivanovsky Institute of Virology. The virus was passaged 10 times in 9 –11 
day old ECE.  The virus-containing material, at a concentration level of 107 PFU mL-1 
(Plaque Forming Units (infectious virions capable of forming plaque) per mL), was 
obtained by culturing on cells 4647 (cells of Cercopetecus Aefiopsis embryo kidney) 
with the subsequent triple freezing/defrosting of the infected cell culture on the МEМ 
Eagle maintenance media (MOD, Cat #11-100-22, ICN Biomedicals, Inc., Aurora, 
OH, USA). Prior to the testing, the media containing Vaccinia virus were kept at a 
temperature of –700С. 
 The viral suspension was diluted and added into a 3-jet Collison Nebulizer 
(BGI Inc., Waltham, MA, USA) that aerosolized viruses during experiments.  
 
Experimental Setup 
The experimental setup developed for the laboratory evaluation of the new 
sampler is schematically shown in Figure 3.  The viral particles were aerosolized 
from the initially prepared suspension by the Collison nebulizer at a flow rate of 6 L 
min-1 with dry and filtered compressed air. The aerosol was then mixed with an 
additional flow of dry and filtered air (at 10 L min-1) and entered the test chamber. 
The dryer was adjusted so the aerosol particles in the chamber had a prevalent size of 
above 1 µm. Thus, the particles aerosolized from the viral suspension contained a 
considerable amount of liquid. This simulated a real-life situation, as single viruses 
(size ~ 0.1 µm) are usually transmitted in air environments on particles-carriers of 
much larger size, which increases their chances to survive the desiccation stress.  
 A 400-L dynamic chamber with the horizontal aerosol flow velocity of 0.1 m 
s-1 was used for the tests (Ryzhikov et al., 1995). Uniform air distribution across the 
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chamber was achieved by using a honeycomb-based flow distribution system. The 
non-uniformity of the aerosol concentration did not exceed 10%.  
 Two identical samplers were placed in the chamber and operated in parallel at 
4 L min-1 for 5 minutes. Each was filled with 50 mL of 2% Hanks solution containing 
bovine serum, a 0.03% solution of silicon anti-foam emulsion (M-30 Dow- Corning, 
30% Dimethylpolysiloxane in water), and antibiotics (100 U mL-1 of penicillin and 
100 µg mL-1 of streptomycin). 
 The concentration and size distribution of particles in the air was monitored 
by an optical aerosol spectrometer (Model 1.108, Grimm Aerosol Technik, Ainring, 
Germany), which has been previously used for real-time measurement of airborne 
bacteria and fungi (Gorny et al., 2001; Wang et al., 2001; Grinshpun et al., 2002).  
The experiments were performed at a relative humidity of 50-70 % and an air 
temperature of 20-24°C. The HEPA filters were installed in the sampling lines 
(between the sampler and the sampling pump) and in the chamber’s exhaust stream to 
protect the laboratory environment from the release of pathogenic viruses.   
 
Viral recovery rate 
The validation tests showed that each droplet generated by the nebulizer could 
carry more than one virus. Such arrangement realistically represents natural 
environment where viral bioaerosols usually travel as clumps attached to other 
particles (Otten and Burge, 1999). On this basis, the droplet count provided by the 
real-time optical aerosol particle counter upstream of the sampler’s inlet could 
significantly underestimate the total concentration of viruses entering the sampler. To 
obtain the information representing the quantity of viral material collected by the 
sampler, a fluorescence dye (C20H10NA2O2, Fluka AG, Buchs, Switzerland) was 
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added into the initial suspension in the nebulizer. The intensity of fluorescence was 
measured in Fluorescence Units (FU) and the relationship between the fluorescence 
intensity and number of microorganisms per mL of the initial suspension was 
established. The Vaccinia viral suspension at a concentration of 1.59 × 106 PFU mL-1 
(after dilution) was aerosolised in the chamber. The total intensity of 0.6 × 106 
fluorescence units was achieved (the corresponding balance was 2.64 PFU per 1 
fluorescence unit). The concentration of Influenza virus in the nebulizer suspension 
was 5 × 107 EID50 mL-1 (after dilution). A fluorescence dye, which provided a 
fluorescence intensity of 1.63 × 106 FU, was added to the Influenza viral suspension 
in the nebulizer at 100 µg mL-1 (1 FU of initial suspension corresponds to 30.7 
EID50).  
 Once the aerosol sampling was completed, the fluid in the sampler’s 
collection vessel was analyzed to determine its fluorescence intensity and viral 
concentration.  
 The recovery rate of the Vaccinia virus was calculated as: 
 
 
      (1) 
 
 
The recovery rate of Influenza virus was determined similarly, except “PFU” was 
substituted with “EID50”.   
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=
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Microbiological Analytical Procedure 
 The fluid samples with the collected Influenza virus were analyzed by titration 
on chicken embryo to determine EID50 mL-1, following the titration procedure 
described in detail by Barrett and Inglis (1985). Titration on the chicken embryo is 
known to be the most precise and reliable procedure to enumerate live Influenza 
viruses (Barrett and Inglis, 1985). Tenfold dilutions of the viral suspension were 
inoculated into the embryonated eggs’ amniotic sac (10 eggs per dilution) with 
subsequent incubation of the eggs for 72 hours. The results of titration were 
expressed in EID50 per mL of suspension. 
 The fluid samples with the collected Vaccinia virus were analyzed using the 
standard plaque assay procedures – most common way to determine live viruses 
representing Orthopoxviruses genera. To perform the procedure, the viral suspension 
was diluted in Erla medium containing antibiotics. Tenfold serial dilutions were 
made, and 100 µL was added to confluent 4647 cell monolayers in 24-well cluster 
plates (Costar, Pleasanton, CA, USA). The cell culture produced from the kidney of 
African green monkey was obtained from the "Flow Laboratories" collection and 
cultivated in the Russian State Research Center of Virology and Biotechnology 
"Vector" (Koltsovo, Russia). Virus was allowed to adsorb for 1 h at 37°C in a 
humidified incubator in a 5% CO2 atmosphere. Cluster plates were rocked every 10 to 
15 min during 1 hour. The fluid was aspirated with an addition of 2 mL of overlay 
1% agar (Difco) on the RPMI-1640 medium (containing 2% FCS and antibiotics). 
The cells were incubated for 48 hours at 37°C in a humidified incubator in a 5% CO2 
atmosphere.  After this, the cell monolayers were stained and plaques were 
enumerated. The results were calculated in PFU per mL  of suspension.  
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 As described above, two different analytical techniques were employed for 
enumeration of live viruses in collecting liquid. They have been chosen as most 
accurate and reliable for particular species representing different microbial families 
(Barrett and Inglis, 1985). Such choice can also be justified by the fact that the raw 
data obtained for Influenza and Vaccinia viruses are not directly compared against 
each other and used separately for following calculations of dimensionless recovery 
rate of each microorganism.  
  
RESULTS 
 
The average pressure drop across the device was about 1550 Pa with the 
variation not exceeding 120 Pa. The evaporative loss of the collection fluid was 
minimal and did not exceed 1% for all experimental runs, which was anticipated 
given the short sampling time.  
The particle size distributions of the virion-containing droplets measured in 
the chamber are shown in Figure 4 for the two test strains. Each data point represents 
the average of five experimental runs. The distributions are statistically identical: 
ANOVA test performed for the particle size range of each Grimm channel revealed 
p>0.05. The majority of particles range from 0.5 to 2 µm with the peak at around 1.1 
µm. These size distributions suggest that the “carrier-to-virus” particle size ratio is 
~101, which is rather common for naturally aerosolized viruses.  
 The results of sampling are presented in Table 1. For the stress-sensitive 
Influenza virus, the fluorescence intensity of the sample obtained with Sampler 1 was 
8 FU. The corresponding viral concentration of 31 EID50 mL-1 resulted in the 
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recovery rate of approximately13%. The second sampler demonstrated a higher 
recovery rate of 27%. The average rate of recovery was 20%.   
As expected, the robust Vaccinia virus revealed much higher recovery with an 
average rate of 89%. It should be noted that many infection-causing viruses (e.g., 
Small Pox, Ebola, etc.) are relatively stress-resistant, especially those strains, which 
can be used in the event of bioterrorism or as a warfare agent.  Therefore, the 
recovery characteristics obtained with Vaccinia seem to be more relevant than the 
data obtained with stress-sensitive microorganisms.  In addition to the sampling 
stress, the drop in the recovery rate observed in this study can partly be attributed to 
the microbial stress associated with the aerosolization of viruses and their transport 
inside the test chamber before entering the sampling inlet. As such generation stress 
would not be relevant for natural sources of viral bioaerosols (infected humans and 
animals, plants, etc.) the recovery rate obtained in natural environments could be 
even higher compared to the laboratory results.  
Overall, the new sampling method was found to be feasible for the detection 
and enumeration of airborne viruses, particularly robust ones.   
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Table 1. Recovery rate of Influenza and Vaccinia viruses after the 5-min collection. 
 
Virus  Fluorescence  
Intensity (FU) 
Virus concentration  
(EID50 mL-1) 
Recovery rate  
(%) 
 
Sampler 1 
 
8 
 
31 
 
13 
 
Sampler 2 
 
6 
 
50 
 
27 
 
Influenza 
 
 
Average  
   
20  
 
Sampler 1 
 
21 
 
47 
 
85 
 
Sampler 2 
 
6 
 
15 
 
94 
 
Vaccinia 
 
Average 
   
89 
 
 
 
 
 
 
 17
Figure Captions. 
Figure 1. Personal sampler prototype. 
Figure 2. Microscopic photographs of the test viruses: Influenza virus (a), and 
Vaccinia virus (b). Both photos are of the same scale [shown on (a)]. 
Figure 3. Experimental setup. 
Figure 4. Particle size distributions of the two aerosolized viral suspensions 
(Influenza and Vaccinia). The data represent the average values and the 
standard deviations of five measurements.  
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